Zota Health Care Limited (NSE:ZOTA)

Market Cap	46.39B +98.2%
Revenue (ttm)	4.73B +92.7%
Net Income	-726.58M
EPS	-24.13
Shares Out	33.77M
PE Ratio	n/a
Forward PE	n/a
Dividend	1.00 (0.07%)
Ex-Dividend Date	Sep 22, 2025

Volume	25,305
Average Volume	63,847
Open	1,380.00
Previous Close	1,373.60
Day's Range	1,346.00 - 1,380.00
52-Week Range	752.00 - 1,740.00
Beta	0.30
RSI	50.69
Earnings Date	Feb 4, 2026

About Zota Health Care

Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company offers generic drugs, health supplements, over-the-counter products, wellness and ayurvedic products, and nutraceutical products. It provides various medicines for chronic ailments, such as diabetes, cardiac, and thyroid disorders. The company operates its retail stores under the DAVAINDIA name. Zota Health Care Limited was founded in 1995 and is headquartered in Surat, India.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1995
• Employees: 519
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ZOTA

Financial Performance

In fiscal year 2025, Zota Health Care's revenue was 2.93 billion, an increase of 62.32% compared to the previous year's 1.80 billion. Losses were -563.98 million, 293.1% more than in 2024.